Three very interesting new papers have been published recently. Manz et al. describes the quality and usefulness of the BÜHLMANN calprotectin ELISA in an observational study to screen for organic vs. non-organic gut disease, which very impressively reflects the daily practice of screening unknown patients with abdominal discomfort. A real time, real life situation reflected.
Social Links